drugset / Trial / NCT00328523

TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)

NCT00328523

Phase 3 Completed 1496 enrolled Organon and Co
RandomizedParallel-groupOpen-labelTreatment

Summary

In patients with primary hypercholesterolemia treated with a statin and with ldl-c above the recommended target goal (esc 2003 recommendations ldl\>=1.15 g/l) to compare the efficacy and the safety of ezetrol added to ongoing statin and non drug therapeutic intervention (patient motivation on diet or physical activities or both).

Timeline

Start
2004-06
Primary completion
2006-01
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg

Indications